Testing an AI agent for donor tissue screening at Evergen surfaces more than technical performance questions. The project ...
There are plenty of options for short certificate programs that pay well and balance accessibility with real professional ...
Cognition Therapeutics, Inc. (NASDAQ: CGTX), today announced that a manuscript entitled, “Phase 2 Study of Zervimesine (CT1812) in Participants with Mild-to-Moderate Dementia with Lewy Bodies (DLB)” ...
Evolve Funds Group Inc. ("Evolve" or the "Manager") is pleased to announce that it has filed a final prospectus with plans to ...